DEXPASS

This brand name is authorized in Turkey

Active ingredients

The drug DEXPASS contains a combination of these active pharmaceutical ingredients (APIs):

1 Dexketoprofen
UNII N674F7L21E - DEXKETOPROFEN TROMETHAMINE

Dexketoprofen belongs to the non-steroidal anti-inflammatory group of drugs. The mechanism of action of Dexketoprofen is related to the reduction of prostaglandin synthesis by the inhibition of cyclooxygenase pathway. Furthermore, the inhibition of the synthesis of prostaglandins could affect other inflammation mediators such as kinins, causing an indirect action which would be additional to the direct action.

Read about Dexketoprofen
2 Paracetamol
UNII 362O9ITL9D - ACETAMINOPHEN

Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.

Read about Paracetamol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02BE51 Paracetamol, combinations excl. psycholeptics N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides
Discover more medicines within N02BE51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TR ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu Identifier(s): 8680881029462, 8680881029479, 8680881029486, 8680881029493, 8680881099625, 8680881099632, 8680881099649, 8680881099656

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.